Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tumor susceptibility 101 | Starlite/ChEMBL | No references |
Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | Human immunodeficiency virus type 1 Tat protein | Starlite/ChEMBL | No references |
Homo sapiens | huntingtin | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | squamous cell carcinoma antigen | Human immunodeficiency virus type 1 Tat protein | 86 aa | 79 aa | 30.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0194 | 0.0522 | 0.0522 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0194 | 0.0522 | 0.0466 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.0824 | 0.3167 | 1 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0194 | 0.0522 | 0.5 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.0824 | 0.3167 | 1 |
Echinococcus multilocularis | prolyl endopeptidase | 0.0194 | 0.0522 | 0.0466 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0194 | 0.0522 | 0.0466 |
Mycobacterium tuberculosis | Probable peptidase | 0.0194 | 0.0522 | 0.5 |
Brugia malayi | hypothetical protein | 0.0148 | 0.0328 | 0.027 |
Trichomonas vaginalis | Clan SC, family S9, acylaminoacyl-peptidase-like serine peptidase | 0.0194 | 0.0522 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0194 | 0.0522 | 0.5 |
Mycobacterium tuberculosis | Probable protease II PtrBb [second part] (oligopeptidase B) | 0.0194 | 0.0522 | 0.5 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.0824 | 0.3167 | 0.3167 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.2451 | 1 | 1 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.0824 | 0.3167 | 1 |
Onchocerca volvulus | Prolyl endopeptidase homolog | 0.0194 | 0.0522 | 0.0201 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.0824 | 0.3167 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0194 | 0.0522 | 0.0466 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.0328 | 0.027 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0194 | 0.0522 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0194 | 0.0522 | 0.5 |
Echinococcus granulosus | prolyl endopeptidase | 0.0194 | 0.0522 | 0.0466 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.0328 | 0.027 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0194 | 0.0522 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.063 | 0.2351 | 0.2306 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0194 | 0.0522 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0194 | 0.0522 | 0.0466 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0194 | 0.0522 | 0.5 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.2451 | 1 | 1 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.0824 | 0.3167 | 0.3127 |
Mycobacterium ulcerans | protease II (oligopeptidase B), PtrB | 0.0194 | 0.0522 | 0.5 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0194 | 0.0522 | 0.0522 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.0824 | 0.3167 | 0.3127 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0194 | 0.0522 | 0.5 |
Schistosoma mansoni | acylaminoacyl-peptidase (S09 family) | 0.0194 | 0.0522 | 0.0522 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.2451 | 1 | 1 |
Echinococcus granulosus | acylamino acid releasing enzyme | 0.0194 | 0.0522 | 0.0466 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.0824 | 0.3167 | 1 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.2451 | 1 | 1 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.0824 | 0.3167 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0194 | 0.0522 | 0.0466 |
Echinococcus multilocularis | acylamino acid releasing enzyme | 0.0194 | 0.0522 | 0.0466 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0194 | 0.0522 | 0.0466 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.2451 | 1 | 1 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0194 | 0.0522 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0194 | 0.0522 | 0.0466 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0194 | 0.0522 | 0.5 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0194 | 0.0522 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0824 | 0.3167 | 0.3127 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0194 | 0.0522 | 0.0522 |
Plasmodium falciparum | peptidase, putative | 0.0194 | 0.0522 | 0.5 |
Brugia malayi | hypothetical protein | 0.063 | 0.2351 | 0.2306 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0194 | 0.0522 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | 4.29 uM | PubChem BioAssay. An HIV-1 Tat-TAR Fluorescence Polarization (FP) Counter Screen to evaluate Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 0.0004 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 11.5701 uM | PubChem BioAssay. qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485342, AID485388] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.